Premium intraocular lenses: The past, present and future.

Jasmin Zvorničanin, Edita Zvorničanin
Author Information
  1. Jasmin Zvorničanin: Department of Ophthalmology, University Clinical Center Tuzla, Bosnia and Herzegovina.
  2. Edita Zvorničanin: Department of Ophthalmology, University Clinical Center Tuzla, Bosnia and Herzegovina.

Abstract

PURPOSE: To present potential benefits as well as limitations of premium intraocular lens (IOL) use, and provide insight in future of premium cataract surgery.
METHODS: Bibliographic research was performed in PubMed/Medline database, and the most recently updated papers were evaluated. Keywords used were: premium intraocular lens, multifocal intraocular lens, toric intraocular lens, toric multifocal intraocular lens, accommodative intraocular lens, and the respective brand names.
RESULTS: Multifocal IOLs provide uncorrected distance visual acuity (UDVA) of 0.03 logMAR in 82.3%-95.7% of patients and overall spectacle independence in 81%-85% of patients. Toric IOLs provide UDVA of 0.3 logMAR in 70%-95% of patients, residual astigmatism of 1 D or less is noted in 67%-88% of patients, and spectacle independence is reported in 60%-85% of patients. Toric multifocal IOLs provide UDVA of 0.3 logMAR in 92%-97% of patients, and spectacle independence is reported in 79%-90% of patients. Accommodative IOLs represent intensively developing field in ophthalmology, and the results are still variable depending on the IOL model.
CONCLUSIONS: Premium IOL technology and advanced surgical techniques have significantly improved postoperative visual outcomes. Future developments will potentiate development of new premium IOL designs that will provide spectacle independence and excellent visual outcomes after cataract surgery.

Keywords

References

  1. Curr Opin Ophthalmol. 1997 Feb;8(1):2-5 [PMID: 10168268]
  2. Acta Ophthalmol Scand. 1999 Oct;77(5):548-51 [PMID: 10551298]
  3. J Cataract Refract Surg. 2003 Jan;29(1):146-52 [PMID: 12551682]
  4. J Cataract Refract Surg. 2003 May;29(5):935-40 [PMID: 12781279]
  5. Bull World Health Organ. 2003;81(10):758-61 [PMID: 14758438]
  6. Ophthalmol Clin North Am. 2006 Mar;19(1):129-34, vii [PMID: 16500534]
  7. J Cataract Refract Surg. 2006 Apr;32(4):565-72 [PMID: 16698473]
  8. J Cataract Refract Surg. 2006 May;32(5):812-25 [PMID: 16765800]
  9. Acta Ophthalmol Scand. 2007 Jun;85(4):409-14 [PMID: 17403026]
  10. J Cataract Refract Surg. 2008 Mar;34(3):368-76 [PMID: 18299059]
  11. Eye (Lond). 2009 Jan;23(1):31-7 [PMID: 18327164]
  12. Am J Ophthalmol. 2008 Aug;146(2):244-250 [PMID: 18501329]
  13. J Cataract Refract Surg. 2008 Sep;34(9):1584-91 [PMID: 18721724]
  14. Curr Opin Ophthalmol. 2009 Jan;20(1):19-24 [PMID: 19077825]
  15. J Cataract Refract Surg. 2009 Jan;35(1):70-5 [PMID: 19101427]
  16. J Cataract Refract Surg. 2009 Jun;35(6):992-7 [PMID: 19465282]
  17. J Cataract Refract Surg. 2009 Jul;35(7):1266-72 [PMID: 19545819]
  18. J Cataract Refract Surg. 2010 Mar;36(3):456-64 [PMID: 20202545]
  19. J Refract Surg. 2011 Jan;27(1):56-62 [PMID: 20415287]
  20. J Cataract Refract Surg. 2010 Aug;36(8):1323-9 [PMID: 20656155]
  21. Ophthalmology. 2010 Nov;117(11):2104-11 [PMID: 20846724]
  22. J Cataract Refract Surg. 2010 Oct;36(10):1700-8 [PMID: 20870116]
  23. Curr Opin Ophthalmol. 2011 Jan;22(1):4-9 [PMID: 21107260]
  24. Clin Exp Optom. 2010 Nov;93(6):441-52 [PMID: 21182659]
  25. Ophthalmology. 2011 Jun;118(6):1055-61 [PMID: 21310493]
  26. Clin Ophthalmol. 2011 Jan 07;5:45-56 [PMID: 21311656]
  27. J Cataract Refract Surg. 2011 May;37(5):859-65 [PMID: 21397457]
  28. J Refract Surg. 2011 Aug;27(8):564-9 [PMID: 21688765]
  29. Ophthalmologe. 2011 Oct;108(10):952-6 [PMID: 21853217]
  30. J Ophthalmol. 2011;2011:284961 [PMID: 21941625]
  31. Br J Ophthalmol. 2012 May;96(5):614-8 [PMID: 22133988]
  32. J Cataract Refract Surg. 2012 Apr;38(4):620-4 [PMID: 22296842]
  33. Med Arh. 2012;66(2):125-8 [PMID: 22486146]
  34. BMC Ophthalmol. 2012 Aug 15;12:41 [PMID: 22894651]
  35. J Cataract Refract Surg. 2012 Oct;38(10):1796-801 [PMID: 22920503]
  36. J Cataract Refract Surg. 2012 Dec;38(12):2080-7 [PMID: 23069271]
  37. Curr Opin Ophthalmol. 2013 Jan;24(1):30-4 [PMID: 23197264]
  38. J Cataract Refract Surg. 2013 May;39(5):673-9 [PMID: 23499065]
  39. J Cataract Refract Surg. 2013 Apr;39(4):624-37 [PMID: 23522584]
  40. J Cataract Refract Surg. 2013 Nov;39(11):1682-90 [PMID: 23993421]
  41. J Cataract Refract Surg. 2013 Oct;39(10):1507-18 [PMID: 24075158]
  42. Case Rep Ophthalmol. 2013 Sep 26;4(3):138-43 [PMID: 24163682]
  43. J Refract Surg. 2013 Nov;29(11):762-7 [PMID: 24203808]
  44. J Cataract Refract Surg. 2014 Feb;40(2):283-94 [PMID: 24461500]
  45. J Cataract Refract Surg. 2014 Feb;40(2):313-22 [PMID: 24461503]
  46. Acta Inform Med. 2014 Apr;22(2):139-41 [PMID: 24825942]
  47. Can J Ophthalmol. 2014 Jun;49(3):297-303 [PMID: 24862779]
  48. Arq Bras Oftalmol. 2014 Apr;77(2):71-5 [PMID: 25076467]
  49. J Optom. 2015 Apr-Jun;8(2):67-76 [PMID: 25248803]
  50. Br J Ophthalmol. 2015 Mar;99(3):405-11 [PMID: 25249611]
  51. J Cataract Refract Surg. 2014 Dec;40(12):2044-9 [PMID: 25283612]
  52. J Refract Surg. 2015 Feb;31(2):124-8 [PMID: 25735046]
  53. Br J Ophthalmol. 2015 Nov;99(11):1466-70 [PMID: 25873650]
  54. J Cataract Refract Surg. 2015 Sep;41(9):2010-3 [PMID: 26471049]
  55. Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6762-9 [PMID: 26567788]
  56. Ophthalmology. 2016 Feb;123(2):275-86 [PMID: 26601819]
  57. Eye Vis (Lond). 2014 Oct 16;1:2 [PMID: 26605349]
  58. Clin Exp Ophthalmol. 2016 May;44(4):260-77 [PMID: 26716602]
  59. J Curr Glaucoma Pract. 2013 May-Aug;7(2):54-7 [PMID: 26997783]
  60. J Cataract Refract Surg. 2016 Feb;42(2):310-28 [PMID: 27026457]
  61. Indian J Ophthalmol. 2016 Apr;64(4):285-91 [PMID: 27221680]
  62. J Refract Surg. 2016 Jul 1;32(7):444-50 [PMID: 27400075]
  63. Clin Exp Optom. 2017 Jan;100(1):49-53 [PMID: 27435335]
  64. Int J Ophthalmol. 2016 Sep 18;9(9):1276-82 [PMID: 27672591]
  65. Ophthalmology. 2017 Jan;124(1):139-141 [PMID: 27743644]
  66. Cochrane Database Syst Rev. 2016 Dec 12;12:CD003169 [PMID: 27943250]
  67. Surv Ophthalmol. 2017 Sep - Oct;62(5):611-634 [PMID: 28366683]
  68. Eur J Ophthalmol. 2017 Jun 26;27(4):387-401 [PMID: 28574135]
  69. Asia Pac J Ophthalmol (Phila). 2017 Jul-Aug;6(4):350-357 [PMID: 28650131]
  70. Eye Vis (Lond). 2017 Jun 26;4:16 [PMID: 28674696]
  71. Asia Pac J Ophthalmol (Phila). 2017 Jul-Aug;6(4):339-349 [PMID: 28780781]
  72. Turk J Ophthalmol. 2017 Aug;47(4):221-225 [PMID: 28845327]
  73. Curr Opin Ophthalmol. 2018 Jan;29(1):48-53 [PMID: 28914687]
  74. Ophthalmology. 2018 Feb;125(2):169-178 [PMID: 28951074]
  75. J Refract Surg. 2017 Oct 1;33(10):690-695 [PMID: 28991337]
  76. Lancet Glob Health. 2017 Dec;5(12):e1221-e1234 [PMID: 29032195]
  77. Indian J Ophthalmol. 2017 Dec;65(12):1314-1322 [PMID: 29208811]
  78. J Cataract Refract Surg. 1987 Sep;13(5):557-60 [PMID: 3312575]
  79. J Cataract Refract Surg. 1994 Sep;20(5):523-6 [PMID: 7996408]
  80. Int Ophthalmol Clin. 1994 Spring;34(2):1-12 [PMID: 8071012]
  81. Ophthalmology. 1996 Aug;103(8 Suppl):S5-16 [PMID: 8764763]
  82. Ophthalmology. 1998 Jul;105(7):1213-21 [PMID: 9663224]

Word Cloud

Created with Highcharts 10.0.0intraocularIOLpatientslensprovidepremiumIOLsspectacleindependencesurgerymultifocalvisualUDVA0logMARToricpresentfuturecataracttoricMultifocal3reportedAccommodativePremiumoutcomeswillPURPOSE:potentialbenefitswelllimitationsuseinsightMETHODS:BibliographicresearchperformedPubMed/MedlinedatabaserecentlyupdatedpapersevaluatedKeywordsusedwere:accommodativerespectivebrandnamesRESULTS:uncorrecteddistanceacuity03823%-957%overall81%-85%70%-95%residualastigmatism1Dlessnoted67%-88%60%-85%92%-97%79%-90%representintensivelydevelopingfieldophthalmologyresultsstillvariabledependingmodelCONCLUSIONS:technologyadvancedsurgicaltechniquessignificantlyimprovedpostoperativeFuturedevelopmentspotentiatedevelopmentnewdesignsexcellentlenses:pastCataract

Similar Articles

Cited By (53)